GlaxoSmithKline Q3 profit increases

GlaxoSmithKline has reported a net profit of GBP1.37 billion, or 26.1 pence per diluted share, for the third quarter ended September 30, 2009, compared to GBP1.06 billion, or 20 pence per diluted share, for the third quarter ended September 30, 2008.

For the third quarter of 2009, operating profit was GBP2.07 billion compared to GBP1.66 billion for the third quarter of 2008.

GSK has reported a turnover of GBP6.76 billion for the third quarter of 2009 compared to GBP5.88 billion for the same period of 2008.

For the first nine months ended September 30, 2009, the company has reported a profit of GBP4 billion, or 76.4 pence per diluted share, compared to GBP3.69 billion, or 68.7 pence per diluted share, for the first nine months ended September 30, 2008.

Operating profit for the first nine-month period of 2009 was GBP5.98 billion compared to GBP5.56 billion for the same period of 2008.

For the first nine months of 2009, the turnover was GBP20.27 billion compared to GBP17.44 billion for the same period of 2008.

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

Related terms: net profit, profit